Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study
- 1 October 2007
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 8 (10) , 889-897
- https://doi.org/10.1016/s1470-2045(07)70279-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant ChemotherapyNew England Journal of Medicine, 2006
- A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung CancerNew England Journal of Medicine, 2006
- Erlotinib in Lung Cancer — Molecular and Clinical Predictors of OutcomeNew England Journal of Medicine, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002
- The new World Health Organization classification of lung tumoursEuropean Respiratory Journal, 2001
- The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomasLung Cancer, 2000
- Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer1Supported by Veterans Affairs Research Service.1Lung Cancer, 1998
- Revisions in the International System for Staging Lung CancerChest, 1997